|
1
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li J, Chen CX and Shen YH: Effects of
total glucosides from paeony (Paeonia lactiflora Pall) roots
on experimental atherosclerosis in rats. J Ethnopharmacol.
135:469–475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hansson GK: Inflammation, atherosclerosis,
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pentikäinen MO, Oörni K, Ala-Korpela M and
Kovanen PT: Modified LDL-trigger of atherosclerosis and
inflammation in the arterial intima. J Intern Med. 247:359–370.
2000.PubMed/NCBI
|
|
5
|
Plihtari R, Kovanen PT and Öörni K:
Acidity increases the uptake of native LDL by human
monocyte-derived macrophages. Atherosclerosis. 217:401–406. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Libby P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002.
View Article : Google Scholar
|
|
7
|
Stein S, Lohmann C, Schäfer N, et al:
SIRT1 decreases Lox-1-mediated foam cell formation in
atherogenesis. Eur Heart J. 31:2301–2309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Levitan I, Volkov S and Subbaiah PV:
Oxidized LDL: diversity, patterns of recognition, and
pathophysiology. Antioxid Redox Signal. 13:39–75. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kakutani M, Masaki T and Sawamura T: A
platelet-endothelium interaction mediated by lectin-like oxidized
low-density lipoprotein receptor-1. Proc Natl Acad Sci USA.
97:360–364. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen M, Kakutani M, Naruko T, et al:
Activation-dependent surface expression of LOX-1 in human
platelets. Biochem Biophys Res Commun. 282:153–158. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kataoka H, Kume N, Miyamoto S, et al:
Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL
receptor-1 in vascular smooth muscle cells. Arterioscler Thromb
Vasc Biol. 21:955–960. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mitra S, Goyal T and Mehta JL: Oxidized
LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther. 25:419–429.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamamoto N, Toyoda M, Abe M, et al:
Lectin-like oxidized LDL receptor-1 (LOX-1) expression in the
tubulointerstitial area likely plays an important role in human
diabetic nephropathy. Intern Med. 48:189–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nagase M, Hirose S, Sawamura T, Masaki T
and Fujita T: Enhanced expression of endothelial oxidized
low-density lipoprotein receptor (LOX-1) in hypertensive rats.
Biochem Biophys Res Commun. 237:496–498. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rautureau Y and Schiffrin EL: Endothelin
in hypertension: an update. Curr Opin Nephrol Hypertens.
21:128–136. 2012. View Article : Google Scholar
|
|
16
|
Taguchi K and Hattori Y: Unlooked-for
significance of cardiac versus vascular effects of endothelin-1 in
the pathophysiology of pulmonary arterial hypertension. Circ Res.
112:227–229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Watson AM, Li J, Schumacher C, et al: The
endothelin receptor antagonist avosentan ameliorates nephropathy
and atherosclerosis in diabetic apolipoprotein E knockout mice.
Diabetologia. 53:192–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rodríguez-Pascual F, Busnadiego O, Lagares
D and Lamas S: Role of endothelin in the cardiovascular system.
Pharmacol Res. 63:463–472. 2011.
|
|
19
|
Morawietz H, Rueckschloss U, Niemann B, et
al: Angiotensin II induces LOX-1, the human endothelial receptor
for oxidized low-density lipoprotein. Circulation. 100:899–902.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Böhm F and Pernow J: The importance of
endothelin-1 for vascular dysfunction in cardiovascular disease.
Cardiovasc Res. 76:8–18. 2007.PubMed/NCBI
|
|
21
|
Xu S, Liu Z, Huang Y, et al: Tanshinone
II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages
by reducing intracellular superoxide radical generation and NF-κB
activation. Transl Res. 160:114–124. 2012.PubMed/NCBI
|
|
22
|
Kang B-Y, Khan JA, Ryu S, Shekhar R, Seung
KB and Mehta JL: Curcumin reduces angiotensin II-mediated
cardiomyocyte growth via LOX-1 inhibition. J Cardiovasc Pharmacol.
55:176–183. 2010.
|
|
23
|
Guan S, Wang B, Li W, Guan J and Fang X:
Effects of berberine on expression of LOX-1 and SR-BI in human
macrophage-derived foam cells induced by ox-LDL. Am J Chin Med.
38:1161–1169. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ou H-C, Song T-Y, Yeh Y-C, et al: EGCG
protects against oxidized LDL-induced endothelial dysfunction by
inhibiting LOX-1-mediated signaling. J Appl Physiol (1985).
108:1745–1756. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang H-C, Chen T-G, Tai Y-T, Chen T-L,
Chiu W-T and Chen R-M: Resveratrol attenuates oxidized LDL-evoked
Lox-1 signaling and consequently protects against apoptotic insults
to cerebrovascular endothelial cells. J Cereb Blood Flow Metab.
31:842–854. 2011. View Article : Google Scholar
|
|
26
|
Kuo C-L, Chi C-W and Liu T-Y: The
anti-inflammatory potential of berberine in vitro and in vivo.
Cancer Lett. 203:127–137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brusq J-M, Ancellin N, Grondin P, et al:
Inhibition of lipid synthesis through activation of AMP kinase: an
additional mechanism for the hypolipidemic effects of berberine. J
Lipid Res. 47:1281–1288. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Puato M, Faggin E, Rattazzi M, et al:
Atorvastatin reduces macrophage accumulation in atherosclerotic
plaques: a comparison of a nonstatin-based regimen in patients
undergoing carotid endarterectomy. Stroke. 41:1163–1168. 2010.
View Article : Google Scholar
|
|
29
|
Zhou G, Ge S, Liu D, et al: Atorvastatin
reduces plaque vulnerability in an atherosclerotic rabbit model by
altering the 5-lipoxygenase pathway. Cardiology. 115:221–228. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Simmons G, McKnight À, Takeuchi Y, Hoshino
H and Clapham PR: Cell-to-cell fusion, but not virus entry in
macrophages by T-cell line tropic HIV-1 strains: a V3
loop-determined restriction. Virology. 209:696–700. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McKnight Á, Griffiths DJ, Dittmar M,
Clapham P and Thomas E: Characterization of a late entry event in
the replication cycle of human immunodeficiency virus type 2. J
Virol. 75:6914–6922. 2001.PubMed/NCBI
|
|
32
|
Sitia S, Tomasoni L, Atzeni F, et al: From
endothelial dysfunction to atherosclerosis. Autoimmun Rev.
9:830–834. 2010. View Article : Google Scholar
|
|
33
|
Pawlak K, Mysliwiec M and Pawlak D:
Oxidized LDL to autoantibodies against oxLDL ratio-the new
biomarker associated with carotid atherosclerosis and
cardiovascular complications in dialyzed patients. Atherosclerosis.
224:252–257. 2012. View Article : Google Scholar
|
|
34
|
Howell KW, Meng X, Fullerton DA, Jin C,
Reece TB and Cleveland JC Jr: Toll-like receptor 4 mediates
oxidized LDL-induced macrophage differentiation to foam cells. J
Surg Res. 171:e27–e31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu J, Mitra S, Wang X, Khaidakov M and
Mehta JL: Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in
atherogenesis and tumorigenesis. Antioxid Redox Signal.
15:2301–2333. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pandey H, Arjuman A, Roy KK and Chandra
NC: Reciprocal coordination of a combination oral contraceptive
containing desogestrel+ethinyl estradiol on the expression of LOX-1
and LDLR in placental trophoblast cells. Contraception. 84:e43–e49.
2011.PubMed/NCBI
|
|
37
|
McMurray JJ, Holman RR, Haffner SM, et al;
NAVIGATOR Study Group. Effect of valsartan on the incidence of
diabetes and cardiovascular events. N Engl J Med. 362:1477–1490.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Morawietz H, Duerrschmidt N, Niemann B,
Galle J, Sawamura T and Holtz J: Induction of the oxLDL receptor
LOX-1 by endothelin-1 in human endothelial cells. Biochem Biophys
Res Commun. 284:961–965. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cani PD, Bibiloni R, Knauf C, et al:
Changes in gut microbiota control metabolic endotoxemia-induced
inflammation in high-fat diet-induced obesity and diabetes in mice.
Diabetes. 57:1470–1481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang X, Dong F, Ren J, Driscoll MJ and
Culver B: High dietary fat induces NADPH oxidase-associated
oxidative stress and inflammation in rat cerebral cortex. Exp
Neurol. 191:318–325. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ju J, Liu Y, Hong J, Huang MT, Conney AH
and Yang CS: Effects of green tea and high-fat diet on arachidonic
acid metabolism and aberrant crypt foci formation in an
azoxymethane-induced colon carcinogenesis mouse model. Nutr Cancer.
46:172–178. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lee JY, Sohn KH, Rhee SH and Hwang D:
Saturated fatty acids, but not unsaturated fatty acids, induce the
expression of cyclooxygenase-2 mediated through Toll-like receptor
4. J Biol Chem. 276:16683–16689. 2001. View Article : Google Scholar : PubMed/NCBI
|
